SCHEMBL1767710

SCHEMBL1767710

OCc1cc2cc(Br)ccc2nc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
KDM4E B2RXH2 1/20 0.49
KMT2A Q03164 3/20 0.42
BACE1 P56817 1/20 0.41
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
CHEK1 O14757 1/20 0.35
GRM1 Q13255 1/20 0.35
NT5E P21589 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.34
MALT1 Q9UDY8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15449064 0.86 ALDH1A1 (0.60) ALDH1A1KDM4EKMT2ABACE1MAPT
SCHEMBL1767828 0.84 KMT2A (0.61) ALDH1A1KDM4EKMT2ABACE1MAPT
SCHEMBL667729 0.83 GRM1 (0.46) ALDH1A1KDM4EKMT2ABACE1MAPT
SCHEMBL1879421 0.79 KDM4E (0.49) ALDH1A1KDM4EKMT2ABACE1MAPT
SCHEMBL14617053 0.79 MAPT (0.57) ALDH1A1KDM4EKMT2AMAPTNPSR1
SCHEMBL6904519 0.79 ALDH1A1 (0.49) ALDH1A1KDM4EKMT2AMAPTNPSR1
SCHEMBL8353989 0.79 KMT2A (0.42) ALDH1A1KDM4EKMT2ABACE1MAPT
SCHEMBL13227192 0.78 MGAM (0.40) ALDH1A1KDM4EKMT2ABACE1MAPT
SCHEMBL3250496 0.78 MAPT (0.49) ALDH1A1KDM4EKMT2ABACE1MAPT
SCHEMBL28827445 0.77 ALDH1A1 (0.50) ALDH1A1KDM4EKMT2AMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8822485-B2 Amino heteroaryl compounds as beta-secretase modulators and methods of use AMGEN INC. (US) 2014-09-02 US disclosed
US-8822485-B2 Amino heteroaryl compounds as beta-secretase modulators and methods of use AMGEN INC. (US) 2014-09-02 US disclosed
US-8822485-B2 Amino heteroaryl compounds as beta-secretase modulators and methods of use AMGEN INC. (US) 2014-09-02 US disclosed
US-20130018064-A1 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use AMGEN INC. (US) 2013-01-17 US disclosed
US-20130018064-A1 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use AMGEN INC. (US) 2013-01-17 US disclosed
US-20130018064-A1 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use AMGEN INC. (US) 2013-01-17 US disclosed
EP-2504330-A1 AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE Amgen Inc. (US) 2012-10-03 EP disclosed
WO-2011063272-A1 AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE AMGEN INC. (US) 2011-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018064-A1 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use BACE1, BACE2, APP ALDH1A1 1850/4885KDM4E 1582/4885KMT2A 1382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.